Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.56
+0.33 (5.30%)
At close: Feb 3, 2026, 4:00 PM EST
6.51
-0.05 (-0.76%)
Pre-market: Feb 4, 2026, 7:51 AM EST

Sagimet Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
213145124---
Market Cap Growth
55.19%16.75%----
Enterprise Value
88-2522---
Last Close Price
6.564.505.42---
PS Ratio
--62.05---
PB Ratio
1.790.931.36---
P/TBV Ratio
1.790.931.36---
EV/Sales Ratio
--11.18---
Debt / Equity Ratio
0.000.000.000.010.010.00
Asset Turnover
--0.03---
Quick Ratio
12.7633.9616.786.1323.2535.97
Current Ratio
13.0634.3017.096.2124.0435.99
Return on Equity (ROE)
-39.78%-36.92%-46.96%-72.58%-39.63%-29.98%
Return on Assets (ROA)
-26.52%-26.49%-29.62%-42.16%-23.16%-17.79%
Return on Capital Employed (ROCE)
-53.90%-35.00%-33.80%-111.90%-41.90%-17.00%
Earnings Yield
-27.03%-31.45%-22.46%---
Buyback Yield / Dilution
-10.81%-199.71%-5565.90%-50.61%-26.95%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q